Description
BSE demat auction for settlement 729 dated October 7, 2025, listing securities and quantities available for auction across 100 scrips.
Summary
BSE has published the demat auction list for Settlement No. 729 dated October 7, 2025. The auction includes 100 scrips with varying quantities available for auction, ranging from 1 share to 159,735 shares. This is a routine settlement mechanism for handling delivery shortfalls in the market.
Key Points
- Settlement number: 729
- Auction date: October 7, 2025
- Total scrips involved: 100
- Largest quantity: WELCURE DRUG (159,735 shares)
- Notable scrips include major companies like State Bank of India (200 shares), TCS (28 shares), Lupin (25 shares), Apollo Hospital (10 shares)
- Quantities range from 1 share to 159,735 shares
Regulatory Changes
No regulatory changes introduced. This is a standard market settlement process.
Compliance Requirements
- Members with shortages in the listed scrips must participate in the demat auction
- Settlement must be completed as per BSE auction procedures
- Defaulting members may face auction obligations and penalties
Important Dates
- Auction Date: October 7, 2025
- Settlement No: 729
Impact Assessment
Market Impact: Low - This is a routine settlement mechanism affecting only specific members with delivery obligations.
Operational Impact: Low to Medium for affected members - Members with shortages must arrange securities or participate in the auction to fulfill delivery obligations.
Investor Impact: Minimal - Only affects specific shareholders whose brokers failed to deliver securities on settlement date. May result in additional costs for affected members who must purchase securities at auction prices.
Impact Justification
Routine demat auction affecting specific shareholders with delivery shortfalls; limited broader market impact